Blog
New

Food Insecurity Increases Risk for Binge Eating Disorder and Obesity

Investigators observed a link between food insecurity — difficulty affording enough food to support regular, balanced meals — and increased probability of binge-eating disorder and obesity, according to study results.

Read More
New

How Should Clinicians Discuss Prognosis With Patients?

Talking to sick patients about their future health prospects is a challenge.

Read More
New

Aripiprazole, Bupropion Augmentation More Cost-Effective Than Just Bupropion

Investigators evaluated the cost-effectiveness of augmentation with either aripiprazole or bupropion in patients with depression compared with switching to a new antidepressant.

Read More
New

Valbenazine May Improve Movement Disorders in Patients With Mood Disorders

An analysis of once-daily valbenazine trials revealed improvements in tardive dyskinesia in patients with mood disorders.

Read More
New

Risk for Depression and Suicidal Ideation Elevated Among Patients With Atopic Dermatitis

Patients with atopic dermatitis have a higher likelihood of clinical depression and suicidality.

Read More
New

Ketamine May Be Equally Effective in Anxious vs Nonanxious Depression

Researchers found that there is a potential for the use of intravenous ketamine for anxious treatment-resistant depression.

Read More
New

FDA: Important Updates to the Clozapine REMS Program

Products covered under the Clozapine REMS program include Clozaril (HLS Therapeutics), Fazaclo (Jazz), and Versacloz (TruPharma), in addition to all generic versions.

Read More
New

Smoking Associated With Worsened Symptoms, Quality of Life in Patients With Psychosis

A negative association between number of cigarettes per day and quality of life was observed in patients with psychosis.

Read More
New

Insomnia Increases Emotional Dysregulation, Impulsivity, and Suicidality in Bipolar Disorder

Sleep has important functions for the regulation of mood and emotion, and treatment of sleep disturbances in bipolar disorder may improve patient outcomes.

Read More
New

NDA Submitted for Novel Insomnia Treatment Lemborexant

The NDA includes data from two Phase 3 clinical trials (SUNRISE 1 and SUNRISE 2) which included approximately 2000 patients.

Read More
New

Childhood Physical Violence Associated With Decreased Total Cholesterol

Investigators examine the link between decreased total cholesterol and childhood physical violence.

Read More
New

How the Government Shutdown Affects FDA Activities

The consequence of the shutdown means the budget appropriated by Congress for the Agency is on hold, resulting in ~7000 of it’s 17,000 employees being furloughed.

Read More
New

The Robot Will See You Now: The Increasing Role of Robotics in Psychiatric Care

Dr Pransky shares some examples of robots that have shown impressive psychiatric applications, as well as her thoughts on giving robots the critical role of delivering healthcare to human beings.

Read More
New

Extended-Release Naltrexone Improves Psychiatric Disorders During Addiction Therapy

Changes in anxiety, depression, or insomnia symptoms were examined in patients with opioid use disorder taking extended-release naltrexone or buprenorphine-naloxone.

Read More
New

Infections, Antibiotics Associated With Subsequent Increased Risk for Mental Disorders in Youth

The risk for mental disorders increased after severe infections requiring hospitalizations in children.

Read More
New

Nonmedical Prescription Opioid Use Motivated by Pain Relief in Adolescence Predicts Later SUD

A set of characteristics of nonmedical use of prescription opioids in adolescents may help identify youth at high risk for substance use disorder, including opioid misuse, in early midlife.

Read More
New

Pregnancy Reduces the Risk for Alcohol Use Disorder Among Women and Their Partners

Despite the reduction in the ability to exercise free will associated with substance use disorders and the severity of these disorders, pregnancy appears to have protective effects.

Read More